These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 34344563)

  • 1. [Colorectal cancer screening program : Test completion rate and follow-up results after selective mailing of the test kit, based on likelihood of participation].
    Koïvogui A; Vincelet C; Ait-Hadad H; Pellissier H; Valibay S; Kaufmanis A; Benamouzig R
    Rev Epidemiol Sante Publique; 2021 Oct; 69(5):265-276. PubMed ID: 34344563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
    Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of stopping sending colorectal cancer screening test kits by regular mail.
    Koïvogui A; Ecochard R; Le Mab G; Benamouzig R
    Public Health; 2019 Aug; 173():33-41. PubMed ID: 31252152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal cancer screening program: cost effectiveness of systematic recall letters.
    Tifratene K; Eisinger F; Rinaldi Y; Didelot R; Seitz JF
    Gastroenterol Clin Biol; 2007 Nov; 31(11):929-33. PubMed ID: 18166880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of encouraging participation in colorectal cancer screening campaigns by motivating people through the social network, Facebook.
    Koïvogui A; Levi S; Finkler M; Lewkowicz S; Gombeaud T; Sabate JM; Duclos C; Benamouzig R
    Colorectal Dis; 2020 Oct; 22(10):1325-1335. PubMed ID: 32397003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Évaluation de la gravité du cancer colorectal dépisté dans le contexte de la crise sanitaire liée au COVID19 en région Ile-de-France].
    Koïvogui A; Abihsera G; Le Trong T; Ait-Hadad H; Bernoux A; Delattre H; Vincelet C; Caroll R; Nicolet J
    Rev Epidemiol Sante Publique; 2023 Oct; 71(5):102124. PubMed ID: 37451076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct mailing of faecal occult blood tests for colorectal cancer screening: a randomized population study from Central Italy.
    Giorgi Rossi P; Grazzini G; Anti M; Baiocchi D; Barca A; Bellardini P; Brezzi S; Camilloni L; Falini P; Maccallini V; Mantellini P; Romeo D; Rubeca T; Venditti MA
    J Med Screen; 2011; 18(3):121-7. PubMed ID: 22045820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct-to-member mailed colorectal cancer screening outreach for Medicaid and Medicare enrollees: Implementation and effectiveness outcomes from the BeneFIT study.
    Coronado GD; Green BB; West II; Schwartz MR; Coury JK; Vollmer WM; Shapiro JA; Petrik AF; Baldwin LM
    Cancer; 2020 Feb; 126(3):540-548. PubMed ID: 31658375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Estimated impact of the current colorectal screening program in France].
    Barré S; Leleu H; Vimont A; Kaufmanis A; Gendre I; Taleb S; De Bels F
    Rev Epidemiol Sante Publique; 2020 Jun; 68(3):171-177. PubMed ID: 32417153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing behavioral interventions to optimize participation in a population-based colorectal cancer screening program in Catalonia, Spain.
    Stoffel S; Benito L; Milà N; Travier N; Binefa G; Vidal C; Espinosa J; Moreno V; Garcia M
    Prev Med; 2019 Feb; 119():58-62. PubMed ID: 30594532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing participation in colorectal cancer screening: results from a cluster randomized trial of directly mailed gFOBT kits to previous nonresponders.
    Tinmouth J; Patel J; Austin PC; Baxter NN; Brouwers MC; Earle C; Levitt C; Lu Y; Mackinnon M; Paszat L; Rabeneck L
    Int J Cancer; 2015 Mar; 136(6):E697-703. PubMed ID: 25195923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional mailing phase for FIT after a medical offer phase: The best way to improve compliance with colorectal cancer screening in France.
    Piette C; Durand G; Bretagne JF; Faivre J
    Dig Liver Dis; 2017 Mar; 49(3):308-311. PubMed ID: 27810401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Program to improve colorectal cancer screening in a low-income, racially diverse population: a randomized controlled trial.
    Jean-Jacques M; Kaleba EO; Gatta JL; Gracia G; Ryan ER; Choucair BN
    Ann Fam Med; 2012; 10(5):412-7. PubMed ID: 22966104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and cost of multilayered colorectal cancer screening promotion interventions at federally qualified health centers in Washington State.
    Kemper KE; Glaze BL; Eastman CL; Waldron RC; Hoover S; Flagg T; Tangka FKL; Subramanian S
    Cancer; 2018 Nov; 124(21):4121-4129. PubMed ID: 30359468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
    Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
    J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice.
    Multicentre Australian Colorectal-neoplasia Screening (MACS) Group
    Med J Aust; 2006 Jun; 184(11):546-50. PubMed ID: 16768659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced Notification Calls Prior to Mailed Fecal Immunochemical Test in Previously Screened Patients: a Randomized Controlled Trial.
    Lee B; Patel S; Rachocki C; Issaka R; Vittinghoff E; Shapiro JA; Ladabaum U; Somsouk M
    J Gen Intern Med; 2020 Oct; 35(10):2858-2864. PubMed ID: 32748345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
    Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
    Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.